We are live on
!
Find out more
CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
22 hedge funds and large institutions have $8.55M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
4% less capital invested
Capital invested by funds: $8.89M → $8.55M (-$340K)
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$635K | |
| 2 | +$601K | |
| 3 | +$113K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$69.2K |
| 5 |
BL
BCWM LLC
Overland Park,
Kansas
|
+$69K |
Top Sellers
| 1 | -$350K | |
| 2 | -$348K | |
| 3 | -$71.7K | |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$21K |
| 5 |
RFWA
RPg Family Wealth Advisory
Burlington,
Massachusetts
|
-$17.9K |